SCNX — Scienture Holdings Share News
0.000.00%
Last trade - 00:00- $5.73m
- $8.72m
- $0.43m
Brief: Scienture Provides Commercial Update On Arbli™, The First FDA-Approved Ready-To-Use Oral Suspension Of Losartan Potassium
Scienture jumps after expanding access to hypertension drug
Scienture Holdings jumps after U.S. FDA clears opioid overdose spray
Brief: Scienture Announces Issuance Of Orange Book-Listable Patent Covering Rezenopy™, The Highest Dosage Naloxone Hcl Nasal Spray Approved By The FDA For Life-Saving Opioid Overdose Emergency Treatment
Brief: Scienture Provides Update On The Commercial Launch Of Rezenopy
Brief: SCIENTURE And BlinkRx Announce Strategic Collaboration To Expand Patient Access To Arbli, The First FDA-Approved Ready-To-Use Oral Suspension Of Losartan Potassium
Brief: SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbli (Losartan Potassium)
Brief: Scienture Holdings Secures GPO Agreements For Arbli Accessing 2500 Institutions
Brief: Scienture Holdings May Offer & Sell Shares Of Common Stock - SEC Filing
Brief: Scienture Secures PBM-Led GPO Deal to Expand Access for Arbli in $256 Million U.S. Losartan Market
Brief: Scienture Holdings Secures $1.2 Million In Bridge Funding
Brief: Scienture Announces Manufacturing And Supply Chain Readiness For ArbliTM, (Losartan Potassium) Oral Suspension, 10Mg/Ml For A Target Product Launch In July 2025
Brief: Scienture Announces The Divestiture Of Its Legacy Subsidiaries
Brief: Scienture Holdings Files Prospectus Relates To Resale From Time To Time Of Up To 2.6 Million Shares Of Common Stock By Selling Stockholders
U.S. STOCKS ON THE MOVE-Fastenal, Target Hospitality , Encore Capital
U.S. STOCKS ON THE MOVE-CoreCivic, Teladoc, Dynavax
U.S. STOCKS ON THE MOVE-Scienture, ARS Pharma, BrightSpring Health
Brief: Scienture To Commercially Launch Rezenopy
Scienture Holdings rises on launch of opioid overdose antidote Rezenopy